Open Label Study of Sildenafil in Patients With Pulmonary Arterial Hypertension

NCT00454207 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Hypertension

Interventions

DRUG: sildenafil citrate (UK-92,480)

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.